Results – Primary Endpoint:
The primary endpoint (dsDNA antibody reduction at week 12) was met with a median dsDNA of 166.3 IU/ml at baseline to 61.1 IU/ml at week 12.
Vaccine-induced tetanus toxoid antibodies and total IgG were similarly reduced.
3/
